In vitro activity of a new echinocandin, LY303366, compared with those of amphotericin B and fluconazole against clinical yeast isolates

被引：58

作者：

Uzun, O ^{[1
]}

Kocagoz, S ^{[1
]}

Cetinkaya, Y ^{[1
]}

Arikan, S ^{[1
]}

Unal, S ^{[1
]}

机构：

[1] HACETTEPE UNIV,SCH MED,DEPT MICROBIOL & CLIN MICROBIOL,TR-06100 ANKARA,TURKEY

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1997年 / 41卷 / 05期

关键词：

D O I：

10.1128/AAC.41.5.1156

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

The in vitro activity of LY303366, a new echinocandin derivative, was evaluated with 191 yeast isolates by a broth microdilution method. The MICs at which 50% of the isolates were inhibited were 0.125 mu g/ml for Candida albicans and C. tropicalis, 0.25 mu g/ml for C. krusei, C. kefyr, and C. glabrata, and 2.0 mu g/ml for C. parapsilosis.

引用

页码：1156 / 1157

页数：2

共 11 条

[1] EMERGENCE OF CANDIDA-KRUSEI INFECTIONS AFTER THERAPY OF OROPHARYNGEAL CANDIDIASIS WITH FLUCONAZOLE [J].

AKOVA, M ;

AKALIN, HE ;

UZUN, O ;

GUR, D .

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1991, 10 (07) :598-599

[2] OPPORTUNISTIC MYCOSES IN THE IMMUNOCOMPROMISED HOST - EXPERIENCE AT A CANCER CENTER AND REVIEW [J].

ANAISSIE, E .

CLINICAL INFECTIOUS DISEASES, 1992, 14 :S43-S53

[3] FLUCONAZOLE SUSCEPTIBILITY TESTING OF CANDIDA-ALBICANS - MICROTITER METHOD THAT IS INDEPENDENT OF INOCULUM SIZE, TEMPERATURE, AND TIME OF READING [J].

ANAISSIE, E ;

PAETZNICK, V ;

BODEY, GP .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (08) :1641-1646

[4] Fluconazole versus amphotericin B in the treatment of hematogenous candidiasis: A matched cohort study [J].

Anaissie, EJ ;

Vartivarian, SE ;

AbiSaid, D ;

Uzun, O ;

Pinczowski, H ;

Kontoyiannis, DP ;

Khoury, P ;

Papadakis, K ;

Gardner, A ;

Raad, II ;

Gilbreath, J ;

Bodey, GP .

AMERICAN JOURNAL OF MEDICINE, 1996, 101 (02) :170-176

[5] SECULAR TRENDS IN NOSOCOMIAL PRIMARY BLOOD-STREAM INFECTIONS IN THE UNITED-STATES, 1980-1989 [J].

BANERJEE, SN ;

EMORI, TG ;

CULVER, DH ;

GAYNES, RP ;

JARVIS, WR ;

HORAN, T ;

EDWARDS, JR ;

TOLSON, J ;

HENDERSON, T ;

MARTONE, WJ .

AMERICAN JOURNAL OF MEDICINE, 1991, 91 :S86-S89

[6] CORRELATION OF IN-VITRO FLUCONAZOLE RESISTANCE OF CANDIDA ISOLATES IN RELATION TO THERAPY AND SYMPTOMS OF INDIVIDUALS SEROPOSITIVE FOR HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 [J].

CAMERON, ML ;

SCHELL, WA ;

BRUCH, S ;

BARTLETT, JA ;

WASKIN, HA ;

PERFECT, JR .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (11) :2449-2453

[7]

HOBAN D, 1996, 36 INT C ANT AG CHEM, P108

[8]

*NAT COMM CLIN LAB, 1995, REF METH BROTH DIL A

[9]

PFALLER MA, 1996, 36 INT C ANT AG CHEM, P108

[10] A RANDOMIZED TRIAL COMPARING FLUCONAZOLE WITH AMPHOTERICIN-B FOR THE TREATMENT OF CANDIDEMIA IN PATIENTS WITHOUT NEUTROPENIA [J].

REX, JH ;

BENNETT, JE ;

SUGAR, AM ;

PAPPAS, PG ;

VANDERHORST, CM ;

EDWARDS, JE ;

WASHBURN, RG ;

SCHELD, WM ;

KARCHMER, AW ;

DINE, AP ;

LEVENSTEIN, MJ ;

WEBB, CD .

NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (20) :1325-1330

← 1 2 →